Clinical Trials Directory

Trials / Terminated

TerminatedNCT03673774

Impedancemetry in Patients Monitored for Pulmonary Hypertension

Prognostic Value of Cardiac Output Measured by Impedancemetry in Patients Monitored for Pulmonary Hypertension

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
59 (actual)
Sponsor
University Hospital, Toulouse · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Monocentric cohort study, prospective, evaluating the variability of cardiac output measurement by resting and stress impedancemetry as a prognostic factor for Pulmonary Hypertension

Detailed description

Cardiac impedancemetry is a technique that allows an electrical representation of cardiac flows. To do this, 6 electrodes are applied to the thorax and a low intensity and high frequency electrical current is transmitted. The impedance is recorded and the variations of the impedance represent the changes in intra-thoracic volume and thus the volume of systolic ejection. This measurement can be done at rest but also during exercise during the walking test. A test of the NO / CO coupled transfer measurement is also performed. The devices that will be used in this project are the Physio-Flow® system and Masterscreen NO / CO coupled transfer measurement device

Conditions

Interventions

TypeNameDescription
DEVICEcardiac impedancemetryThe cardiac output is measured by impedance measurement at rest and during the walking test.

Timeline

Start date
2017-08-23
Primary completion
2021-01-01
Completion
2021-01-01
First posted
2018-09-17
Last updated
2023-07-12

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03673774. Inclusion in this directory is not an endorsement.